Correlation Between Crispr Therapeutics and Ginkgo Bioworks
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Ginkgo Bioworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Ginkgo Bioworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Ginkgo Bioworks Holdings, you can compare the effects of market volatilities on Crispr Therapeutics and Ginkgo Bioworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Ginkgo Bioworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Ginkgo Bioworks.
Diversification Opportunities for Crispr Therapeutics and Ginkgo Bioworks
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Crispr and Ginkgo is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Ginkgo Bioworks Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ginkgo Bioworks Holdings and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Ginkgo Bioworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ginkgo Bioworks Holdings has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Ginkgo Bioworks go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Ginkgo Bioworks
Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 0.56 times more return on investment than Ginkgo Bioworks. However, Crispr Therapeutics AG is 1.78 times less risky than Ginkgo Bioworks. It trades about 0.01 of its potential returns per unit of risk. Ginkgo Bioworks Holdings is currently generating about -0.02 per unit of risk. If you would invest 4,572 in Crispr Therapeutics AG on November 1, 2024 and sell it today you would lose (368.00) from holding Crispr Therapeutics AG or give up 8.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Ginkgo Bioworks Holdings
Performance |
| Timeline |
| Crispr Therapeutics |
| Ginkgo Bioworks Holdings |
Crispr Therapeutics and Ginkgo Bioworks Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Ginkgo Bioworks
The main advantage of trading using opposite Crispr Therapeutics and Ginkgo Bioworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Ginkgo Bioworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will offset losses from the drop in Ginkgo Bioworks' long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Ginkgo Bioworks vs. Surrozen | Ginkgo Bioworks vs. Armata Pharmaceuticals | Ginkgo Bioworks vs. Pasithea Therapeutics Corp | Ginkgo Bioworks vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |